FDA.reportPublic FDA data

9 HR Daytrana 3.33 MG/HR Transdermal System

RxCUI
753443
RxNorm name
9 HR Daytrana 3.33 MG/HR Transdermal System
Display name
9 HR Daytrana 3.33 MG/HR Transdermal System
Full name
9 HR Daytrana 3.33 MG/HR Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DaytranaMETHYLPHENIDATENoven Therapeutics, LLC2c312c31-3198-4775-91ab-294e0b4b9e7f2025-09-01Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 753443

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2c312c31-3198-4775-91ab-294e0b4b9e7fDaytrana 30 MG/9HR Transdermal System [PSN] · 9 HR methylphenidate 3.33 MG/HR Transdermal System [Daytrana] [SBD] · 9 HR Daytrana 3.33 MG/HR Transdermal System [SY] · Daytrana 30 MG per 9HR Transdermal Patch [SY] · Daytrana 30 MG/9HR Transdermal System [SY]529These highlights do not include all the information needed to use DAYTRANA ® safely and effectively. See full prescribing information for DAYTRANA. DAYTRANA ® (methylphenidate transdermal system), CII Initial U.S. Approval: 200620250901